Concepedia

Ori Kalid

OK

13

Publications

1.6K

Citations

13

H-Index

2004

Active since

Affiliations

Karyopharm Therapeutics (United States)(Current)

Tel Aviv University

Bar-Ilan University

Cystic Fibrosis Foundation

Schrodinger (United States)

Ori Kalid is an author at Karyopharm Therapeutics (United States) specializing in medicine, molecular biology, and natural sciences.

Top concepts

MedicineNatural SciencesMolecular BiologyBiochemistryDrug DiscoveryStructural BiologyBiophysicsCell PhysiologyProtein FoldingSmall Molecules

Publications per year

2004–2020

13

Publications

13

Genomic and molecular characterization of esophageal squamous cell carcinoma

De‐Chen Lin, Jia‐Jie Hao, Yasunobu Nagata et al. · Nature Genetics · 2014 · 656 citations · Full text

Molecular Characterization, Esophagus, Aerodigestive Cancer +6

Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands

Dora Toledo Warshaviak, G. Golan, Kenneth Borrelli et al. · Journal of Chemical Information and Modeling · 2014 · 149 citations

Hit Identification, Protein Assembly, Molecular Biology +20

G protein-coupled receptors: <i>In silico</i> drug discovery in 3D

Oren M. Becker, Yael Marantz, Sharon Shacham et al. · Proceedings of the National Academy of Sciences · 2004 · 146 citations · Full text

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

Elena Campaner, Alessandra Rustighi, Alessandro Zannini et al. · Nature Communications · 2017 · 142 citations · Full text

PREDICT modeling and in‐silico screening for G‐protein coupled receptors

Sharon Shacham, Yael Marantz, Shay Bar‐Haim et al. · Proteins Structure Function and Bioinformatics · 2004 · 104 citations

Rows per page

1–5 of 13